Compile Data Set for Download or QSAR
Report error Found 114 Enz. Inhib. hit(s) with all data for entry = 13358
TargetDiacylglycerol kinase alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM783655(US12454531, Example 55)
Affinity DataIC50: 10nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetDiacylglycerol kinase alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM783609(Methyl 2-((2R,5S)-4-(6-cyano-1-methyl-2-oxo-1,2-di...)
Affinity DataIC50: 20nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetDiacylglycerol kinase alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM783632(US12454531, Example 30)
Affinity DataIC50: 20nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetDiacylglycerol kinase alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM783605(Isopropyl 2-((2R,5S)-4-(6-cyano-1-methyl-2-oxo-1,2...)
Affinity DataIC50: 30nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetDiacylglycerol kinase alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM783607(Methyl 2-((2R,5S)-4-(6-cyano-1-methyl-2-oxo-1,2-di...)
Affinity DataIC50: 40nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetDiacylglycerol kinase alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM783633(Methyl 3-((2R,5S)-4-(6-cyano-1-methyl-2-oxo-1,2-di...)
Affinity DataIC50: 50nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetDiacylglycerol kinase alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM783659(3-(3-(but-3-yn-1-yl)-3H-diazirin-3-yl)propyl 2-((2...)
Affinity DataIC50: 70nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetDiacylglycerol kinase alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM783661(2-(3-methyl-3H-diazirin-3-yl)ethyl 2-((2R,5S)-4-(6...)
Affinity DataIC50: 80nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetDiacylglycerol kinase zeta(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM783656(US12454531, Example 56)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetDiacylglycerol kinase alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM783547(Isopropyl 2-((2R,5S)-4-(6-cyano-1-methyl-2-oxo-1,2...)
Affinity DataIC50: 110nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetDiacylglycerol kinase zeta(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM783605(Isopropyl 2-((2R,5S)-4-(6-cyano-1-methyl-2-oxo-1,2...)
Affinity DataIC50: 120nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetDiacylglycerol kinase zeta(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM783632(US12454531, Example 30)
Affinity DataIC50: 140nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetDiacylglycerol kinase alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM783663(2-(2-(2-(3',6'-dihydroxy-3-oxo-3H-spiro[isobenzofu...)
Affinity DataIC50: 160nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetDiacylglycerol kinase alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM783660(3-(3-(but-3-yn-1-yl)-3H-diazirin-3-yl)propyl 2-((2...)
Affinity DataIC50: 180nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetDiacylglycerol kinase zeta(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM783661(2-(3-methyl-3H-diazirin-3-yl)ethyl 2-((2R,5S)-4-(6...)
Affinity DataIC50: 190nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetDiacylglycerol kinase zeta(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM783659(3-(3-(but-3-yn-1-yl)-3H-diazirin-3-yl)propyl 2-((2...)
Affinity DataIC50: 190nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetDiacylglycerol kinase alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM783606(Methyl 2-((2R,5S)-4-(6-cyano-1-methyl-2-oxo-1,2-di...)
Affinity DataIC50: 190nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetDiacylglycerol kinase alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM783654(4-((2S,5R)-2,5-diethyl-4-(2-morpholino-2-oxo-1-(4-...)
Affinity DataIC50: 260nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetDiacylglycerol kinase alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM783610(Methyl 2-((2R,5S)-4-(6-cyano-1-methyl-2-oxo-1,2-di...)
Affinity DataIC50: 380nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetDiacylglycerol kinase zeta(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM783643(US12454531, Example 41)
Affinity DataIC50: 390nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetDiacylglycerol kinase zeta(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM783663(2-(2-(2-(3',6'-dihydroxy-3-oxo-3H-spiro[isobenzofu...)
Affinity DataIC50: 410nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetDiacylglycerol kinase alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM783618(US12454531, Example 16)
Affinity DataIC50: 500nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetDiacylglycerol kinase alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM783613((8-((2S,5R)-4-(1-(4-fluorophenyl)-2-oxo-2-(piperid...)
Affinity DataIC50: 510nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetDiacylglycerol kinase zeta(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM783633(Methyl 3-((2R,5S)-4-(6-cyano-1-methyl-2-oxo-1,2-di...)
Affinity DataIC50: 560nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetDiacylglycerol kinase zeta(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM783654(4-((2S,5R)-2,5-diethyl-4-(2-morpholino-2-oxo-1-(4-...)
Affinity DataIC50: 580nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetDiacylglycerol kinase zeta(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM783609(Methyl 2-((2R,5S)-4-(6-cyano-1-methyl-2-oxo-1,2-di...)
Affinity DataIC50: 700nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetDiacylglycerol kinase alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM783627(US12454531, Example 25)
Affinity DataIC50: 710nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetDiacylglycerol kinase zeta(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM783547(Isopropyl 2-((2R,5S)-4-(6-cyano-1-methyl-2-oxo-1,2...)
Affinity DataIC50: 820nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetDiacylglycerol kinase alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM783644(US12454531, Example 42)
Affinity DataIC50: 830nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetDiacylglycerol kinase alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM783643(US12454531, Example 41)
Affinity DataIC50: 1.14E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetDiacylglycerol kinase alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM783630(US12454531, Example 28)
Affinity DataIC50: 1.19E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetDiacylglycerol kinase zeta(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM783613((8-((2S,5R)-4-(1-(4-fluorophenyl)-2-oxo-2-(piperid...)
Affinity DataIC50: 1.22E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetDiacylglycerol kinase zeta(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM783618(US12454531, Example 16)
Affinity DataIC50: 1.34E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetDiacylglycerol kinase alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM783634(Methyl 3-((2R,5S)-4-(6-cyano-1-methyl-2-oxo-1,2-di...)
Affinity DataIC50: 1.40E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetDiacylglycerol kinase alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM783629(US12454531, Example 27)
Affinity DataIC50: 1.43E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetDiacylglycerol kinase zeta(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM783607(Methyl 2-((2R,5S)-4-(6-cyano-1-methyl-2-oxo-1,2-di...)
Affinity DataIC50: 1.47E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetDiacylglycerol kinase alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM783653(4-((2S,5R)-2,5-diethyl-4-(2-morpholino-2-oxo-1-(4-...)
Affinity DataIC50: 1.97E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetDiacylglycerol kinase alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM783608(2-((2R,5S)-4-(6-cyano-1-methyl-2-oxo-1,2-dihydro-1...)
Affinity DataIC50: 2.04E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetDiacylglycerol kinase alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM783626(US12454531, Example 24)
Affinity DataIC50: 2.39E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetDiacylglycerol kinase zeta(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM783631(US12454531, Example 29)
Affinity DataIC50: 2.44E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetDiacylglycerol kinase alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM783619(US12454531, Example 17)
Affinity DataIC50: 2.56E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetDiacylglycerol kinase zeta(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM783629(US12454531, Example 27)
Affinity DataIC50: 2.88E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetDiacylglycerol kinase zeta(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM783608(2-((2R,5S)-4-(6-cyano-1-methyl-2-oxo-1,2-dihydro-1...)
Affinity DataIC50: 3.27E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetDiacylglycerol kinase zeta(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM783653(4-((2S,5R)-2,5-diethyl-4-(2-morpholino-2-oxo-1-(4-...)
Affinity DataIC50: 3.29E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetDiacylglycerol kinase zeta(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM783610(Methyl 2-((2R,5S)-4-(6-cyano-1-methyl-2-oxo-1,2-di...)
Affinity DataIC50: 3.33E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetDiacylglycerol kinase alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM783636(N-(tert-butyl)-3-((2R,5S)-4-(6-cyano-1-methyl-2-ox...)
Affinity DataIC50: 4.04E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetDiacylglycerol kinase zeta(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM783644(US12454531, Example 42)
Affinity DataIC50: 4.12E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetDiacylglycerol kinase zeta(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM783606(Methyl 2-((2R,5S)-4-(6-cyano-1-methyl-2-oxo-1,2-di...)
Affinity DataIC50: 4.66E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetDiacylglycerol kinase zeta(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM783634(Methyl 3-((2R,5S)-4-(6-cyano-1-methyl-2-oxo-1,2-di...)
Affinity DataIC50: 4.69E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

TargetDiacylglycerol kinase zeta(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM783627(US12454531, Example 25)
Affinity DataIC50: 4.74E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/17/2026
Entry Details US Patent

Displayed 1 to 50 (of 114 total ) | Next | Last >>
Jump to: